Mark Hennies Selected Research

Mark Hennies Research Topics

3	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2019
3	Infections 04/2021 - 04/2017
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Hypersensitivity (Allergy) 09/2019 - 01/2019
1	Pulmonary Hypertension 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	COVID-19 01/2021
1	Cytokine Release Syndrome 01/2021
1	Leukocytosis (Pleocytosis) 09/2019
1	Leukopenia 09/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Shock 01/2019
1	Chronic Renal Insufficiency 05/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2015
1	Kidney Diseases (Kidney Disease) 05/2015

2	Complement System Proteins (Complement)IBA 01/2021 - 09/2019
1	mRNA VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Lipid NanoparticlesIBA 01/2022
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 04/2021
1	CytokinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Complement Factor H (Factor H)IBA 01/2021
1	Liposomes (Liposome)IBA 09/2019
1	ZymosanIBA 01/2019
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2019
1	liposomal amphotericin B FDA Link 01/2019
1	SB 290157IBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	IgYIBA 05/2018
1	AntibodiesIBA 04/2017
1	Human Serum Albumin FDA LinkGeneric 05/2015
1	Peptides (Polypeptides)IBA 05/2015

1	Resuscitation 01/2022
1	Therapeutics 01/2021